Globus Medical
GMED
390 hedge funds and large institutions have $5.57B invested in Globus Medical in 2022 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 143 increasing their positions, 118 reducing their positions, and 44 closing their positions.
1,777% more call options, than puts
Call options by funds: $22.3M | Put options by funds: $1.19M
55% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 44
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
21% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 118
16% more capital invested
Capital invested by funds: $4.8B → $5.57B (+$768M)
5% more funds holding
Funds holding: 370 → 390 (+20)
7.62% less ownership
Funds ownership: 105.59% → 97.97% (-7.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$111M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$37.5M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$18.1M |
| 4 |
BlackRock
New York
|
+$14.9M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$575M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$20.3M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
-$18.5M |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$11.5M |
| 5 |
Morgan Stanley
New York
|
-$8.44M |
GMED Hedge Fund Activity: Q4 2022 in Review
390 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2022, worth a combined $5.57B — up 16% from $4.8B a quarter earlier.
Buyers outnumbered sellers: 68 funds opened new GMED positions and 44 closed out — a net gain of 24 holders — while 143 added to existing stakes and 118 trimmed.
The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $111M. The largest seller was Janus Henderson Group, cutting an estimated $575M.
- 390 institutional investors held Globus Medical (GMED) as of Q4 2022, up from 370 in Q3 2022.
- Funds reported $5.57B of Globus Medical stock for Q4 2022, up 16% quarter-over-quarter.
- 68 funds opened new Globus Medical positions in Q4 2022 and 44 closed out, a net change of +24 holders.
- The largest Globus Medical buyer in Q4 2022 was Kayne Anderson Rudnick Investment Management, an estimated $111M added.
- The largest Globus Medical seller in Q4 2022 was Janus Henderson Group, an estimated $575M sold.
Based on aggregated 13F filings for Q4 2022.